73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study opens route to overcoming drug resistance in stomach cancer

Study opens route to overcoming drug resistance in stomach cancer

by Institute of Cancer ResearchStomach cancer cells. Credit: Katharina von LogaScientists have shown how stomach cancers can dodge the effects of a promising new experimental treatment—raising th

Study opens route to overcoming drug resistance in stomach cancer

by Institute of Cancer ResearchStomach cancer cells. Credit: Katharina von LogaScientists have shown how stomach cancers can dodge the effects of a promising new experimental treatment—raising th
New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit
Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283
Study: Risk of cancer doubles for people with 'skewed' blood cells

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)
A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

by The University of Hong KongGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111821A research team from LKS Faculty of Medicine, the University of Hong Kong

A new tumor-suppressive gene that boosts personalized treatment response in breast cancer

by The University of Hong KongGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111821A research team from LKS Faculty of Medicine, the University of Hong Kong
Survivorship standards help address the distinct needs of adult cancer survivors

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat
Cancer drug data release set to power next wave of therapeutic discovery

Cancer drug data release set to power next wave of therapeutic discovery

by Wellcome Sanger InstituteCredit: CC0 Public DomainThis week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and explora

Cancer drug data release set to power next wave of therapeutic discovery

by Wellcome Sanger InstituteCredit: CC0 Public DomainThis week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and explora
Stopping a rare childhood cancer in its tracks

Stopping a rare childhood cancer in its tracks

byCold Spring Harbor LaboratoryScientists discovered targeting a protein called ETV6 can turn Ewing sarcoma cancer cells back to normal-looking and -behaving connective tissue cells, as seen abo

Stopping a rare childhood cancer in its tracks

byCold Spring Harbor LaboratoryScientists discovered targeting a protein called ETV6 can turn Ewing sarcoma cancer cells back to normal-looking and -behaving connective tissue cells, as seen abo
Researchers identify novel gene networks associated with aggressive type of breast cancer

Researchers identify novel gene networks associated with aggressive type of breast cancer

by Savannah Williamson,Georgia Institute of TechnologyGene enrichment for select Basal-like network modules. Network diagram for eight nonconserved Basal-like modules that include OS genes. Node

Researchers identify novel gene networks associated with aggressive type of breast cancer

by Savannah Williamson,Georgia Institute of TechnologyGene enrichment for select Basal-like network modules. Network diagram for eight nonconserved Basal-like modules that include OS genes. Node
Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita
Important to be open to discussing sex with young cancer survivors

Important to be open to discussing sex with young cancer survivors

by University of GothenburgCredit: University of GothenburgFeeling unattractive and dissatisfied with their sexual ability – that is reality for many teenage and young adult cancer survivors. Res

Important to be open to discussing sex with young cancer survivors

by University of GothenburgCredit: University of GothenburgFeeling unattractive and dissatisfied with their sexual ability – that is reality for many teenage and young adult cancer survivors. Res
Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta